FAQs - Mental Health

GeneSight analyzes certain genes and predicts their combined influence on each patient's response to psychotropic medications. That helps identify the right medication options for patients to improve outcomes.

GeneSight has shown clinical utility in treating treatment-resistant depression. Clinical studies from primary care and psychiatric care demonstrate a 50% improvement in remission and a 30% improvement in response. The GeneSight Psychotropic test analyzes how genes may affect outcomes with medications commonly prescribed to treat depression, anxiety, ADHD, and other mental health conditions.

The GeneSight Psychotropic test is a pharmacogenomic test that analyzes clinically important genetic variations which may impact how your patient metabolizes and responds to certain medications used to treat mental health conditions.

A variety of patients can benefit from the GeneSight test:

• New patients with a previous medication failure
• Patients who are experiencing lower than desired medication response
• Patients who are currently experiencing unwanted side effects
• Elderly patients and patients with liver damage

Your doctor must order the GeneSight test for you. The patient collection kit allows you to collect the DNA sample from the comfort of your home.

GeneSight analyzes how genes may affect medication outcomes. Results can inform a physician about how a patient may break down or respond to certain medications commonly prescribed to treat depression, anxiety, ADHD, and other psychiatric conditions.